Romain Dambre
Partner
New York
Romain Dambre
Partner
New York
Contact Details
Romain advises public and private companies, as well as financial sponsors and their portfolio companies, on a wide variety of domestic and cross-border transactions, including acquisitions, leveraged buyouts, take-privates, divestitures, carve-outs, joint ventures, equity financings and corporate restructurings.
Romain has extensive experience counseling clients in a variety of industries, including technology, life sciences, consumer goods, chemical and infrastructure, among others. He also counsels public companies and their boards of directors and special committees on corporate governance, shareholder activism and takeover defense, securities and other general corporate matters.
Romain has advised clients on numerous significant matters, totaling over $250 billion in value.
Qualifications
Professional
Academic
Yale Law School LL.M., Editor, Yale Journal on Regulation
Sorbonne Law School Ph.D. summa cum laude
Sorbonne Law School J.D. magna cum laude, Salutatorian
HEC Paris M.Sc., List of Excellence
Experience highlights
Celanese in its USB11bn acquisition of DuPont’s Mobility & Materials global business
EQT Infrastructure in its USD5.3 billion take-private acquisition of Covanta
Grubhub in its USD7.3 billion sale to Just Eat Takeaway.com
GlaxoSmithKline in its USD12.7 billion worldwide consumer health joint venture with Pfizer
Related articles
News: 13 March 2023
Allen & Overy expands U.S. M&A and Private Equity team with partner Romain Dambre
Allen & Overy (“A&O”) today announced that Romain Dambre has joined the firm as a partner in its U.S. Corporate practice. Romain joins A&O’s New York office from Kirkland & Ellis, where he was a…
Qualifications
Professional
Academic
Yale Law School LL.M., Editor, Yale Journal on Regulation
Sorbonne Law School Ph.D. summa cum laude
Sorbonne Law School J.D. magna cum laude, Salutatorian
HEC Paris M.Sc., List of Excellence
Other noteworthy experience
Advising:
Private equity firms, financial sponsors, SPACs and family offices, including Advent, Altaris, Apax, Blackstone, Carlyle, EQT, Greenbriar, MacAndrews & Forbes, Ridgemont Equity Partners, and their portfolio companies, in acquisitions and divestitures
Public and private companies in their domestic and cross-border strategic transactions, including:
- Celanese in its $1.15 billion acquisition of ExxonMobil’s Santoprene global business
- Charter Communications in its streaming joint venture with Comcast
- Eli Lilly in its acquisition of Protomer Technologies for a transaction value of over $1.0 billion
- Equity One in its $15.6 billion merger of equals with Regency Centers
- Fortive Corporation in its $2 billion acquisition of Accruent
- Huntsman in its proposed $20 billion merger of equals with Clariant
- Infineon Technologies in its $10.1 billion acquisition of Cypress Semiconductor
- Micro Focus in its $8.8 billion acquisition of Hewlett Packard Enterprise’s global software business
- Travelport Worldwide in its $4.4 billion sale to affiliates of Elliott Management and Siris Capital
- WellCare Health Plans in its $17.3 billion sale to Centene
Published work
- “Initial Coin Offerings and U.S. Securities Regulation: Challenges and Perspectives,” 1 Int’l J. Fin. Serv. 9 (2018)
- Equity Derivatives: French and EU Corporate Law Aspects (Larcier eds., 1st ed. 2016, 527 pp.) (in French)
- “Hedging by Corporate Executives: Three Regulatory Models,” 1/2 Rev. Trim. Dr. Fin. 59 (2015) (in French)
- “A Transalpine Look at Equity Derivatives: Convergence and Divergence in Disclosure and Takeover Regulations in the EU,” 3 Rev. Trim. Dr. Fin. 64 (2012) (with Marco Dell’Erba)
